Active substance
Human c1 esterase inhibitor
- SFDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Berinert | 500 IU | Powder and solvent for solution for injection/infusion · Intravenous use | 1 Vial | SAR 2624.95 | Biological · Prescription | CSL | Valid |
| Cinryze | 500 IU | Powder and solvent for solution for injection · Intravenous use | 2 Vial | SAR 5043.00 | Biological · Prescription | Takeda Manufacturing Austria AG | Valid |
| Haegarda | 2000 IU | Powder and solvent for solution for injection · Subcutaneous use | 1 Vial | SAR 10499.80 | Biological · Prescription | CSL | Valid |
| Haegarda | 3000 IU | Powder and solvent for solution for injection · Subcutaneous use | 1 Vial | SAR 15749.70 | Biological · Prescription | CSL | Valid |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.